These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 2384606)

  • 1. Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.
    Davies RW; Staprans I; Hutchison FN; Kaysen GA
    J Clin Invest; 1990 Aug; 86(2):600-5. PubMed ID: 2384606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome.
    Shearer GC; Stevenson FT; Atkinson DN; Jones H; Staprans I; Kaysen GA
    Kidney Int; 2001 Jan; 59(1):179-89. PubMed ID: 11135070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms.
    Shearer GC; Kaysen GA
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S119-22. PubMed ID: 11158876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen effects on triglyceride metabolism in analbuminemic rats.
    Shearer GC; Joles JA; Jones H; Walzem RL; Kaysen GA
    Kidney Int; 2000 Jun; 57(6):2268-74. PubMed ID: 10844597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrotic hyperlipidemia: primary abnormalities in both lipoprotein catabolism and synthesis.
    Kaysen GA
    Miner Electrolyte Metab; 1992; 18(2-5):212-6. PubMed ID: 1465061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels.
    Wang L; Shearer GC; Budamagunta MS; Voss JC; Molfino A; Kaysen GA
    Kidney Int; 2012 Nov; 82(9):990-9. PubMed ID: 22785171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High protein diets stimulate albumin synthesis at the site of albumin mRNA transcription.
    Kaysen GA; Jones H; Hutchison FN
    Kidney Int Suppl; 1989 Nov; 27():S168-72. PubMed ID: 2561516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction in proteinuria attenuates hyperlipidemia in the nephrotic syndrome.
    Kaysen GA; Davies RW
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S75-9. PubMed ID: 16989070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperlipoproteinemia of aminonucleoside-induced nephrotic syndrome--modulation by glucocorticoids and triiodothyronine.
    Shafrir E
    Isr J Med Sci; 1996 Jun; 32(6):390-7. PubMed ID: 8682644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and consequences of proteinuria.
    Kaysen GA; Myers BD; Couser WG; Rabkin R; Felts JM
    Lab Invest; 1986 May; 54(5):479-98. PubMed ID: 3517485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion.
    Shearer GC; Kaysen GA
    Kidney Int; 2006 Aug; 70(4):647-53. PubMed ID: 16807550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats.
    Joles JA; van Goor H; van der Horst ML; van Tol A; Elema JD; Koomans HA
    Lab Invest; 1995 Dec; 73(6):912-21. PubMed ID: 8558854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catabolic defect of triglyceride is associated with abnormal very-low-density lipoprotein in experimental nephrosis.
    Furukawa S; Hirano T; Mamo JC; Nagano S; Takahashi T
    Metabolism; 1990 Jan; 39(1):101-7. PubMed ID: 2294370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein gene expression in analbuminemic rats and in rats with Heymann nephritis.
    Sun X; Jones H; Joles JA; van Tol A; Kaysen GA
    Am J Physiol; 1992 May; 262(5 Pt 2):F755-61. PubMed ID: 1590420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental nephrotic syndrome: removal and tissue distribution of chylomicrons and very-low-density lipoproteins of normal and nephrotic origin.
    Levy E; Ziv E; Bar-On H; Shafrir E
    Biochim Biophys Acta; 1990 Apr; 1043(3):259-66. PubMed ID: 2322571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein restriction and AST-120 improve lipoprotein lipase and VLDL receptor in focal glomerulosclerosis.
    Sato T; Liang K; Vaziri ND
    Kidney Int; 2003 Nov; 64(5):1780-6. PubMed ID: 14531811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG; Kaysen GA; Barrett HA; Stellaard F; Gadellaa MM; Voorbij HA; Reijngoud DJ; Rabelink TJ
    Kidney Int; 1998 Apr; 53(4):994-1001. PubMed ID: 9551409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome.
    Tarugi P; Nicolini S; Albertazzi L; Calandra S; Salvati P; Ferti C; Patrono C
    J Lipid Res; 1991 Oct; 32(10):1675-87. PubMed ID: 1797947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL.
    Shearer GC; Couser WG; Kaysen GA
    Kidney Int; 2004 Jan; 65(1):228-37. PubMed ID: 14675054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein synthesis in patients with low-grade nephrotic proteinuria.
    Zanetti M; Barazzoni R; Garibotto G; Davanzo G; Gabelli C; Kiwanuka E; Piccoli A; Tosolini M; Tessari P
    Am J Physiol Endocrinol Metab; 2001 Apr; 280(4):E591-7. PubMed ID: 11254466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.